| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.536 | 8.814 | 11.076 | 11.851 | 7.900 | 5.284 | 4.053 | 4.066 | 9.653 | 12.095 |
| Total Income - EUR | 15.252 | 18.945 | 18.738 | 11.851 | 7.900 | 5.298 | 4.053 | 4.066 | 9.653 | 12.095 |
| Total Expenses - EUR | 13.139 | 17.831 | 18.001 | 6.583 | 2.100 | 3.825 | 2.305 | 547 | 5.709 | 6.763 |
| Gross Profit/Loss - EUR | 2.113 | 1.114 | 737 | 5.269 | 5.801 | 1.473 | 1.748 | 3.519 | 3.944 | 5.331 |
| Net Profit/Loss - EUR | 1.655 | 546 | 174 | 4.913 | 5.564 | 1.314 | 1.626 | 3.397 | 3.326 | 4.345 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Dr. Birjovanu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.863 | 21.866 | 4.290 | -561 | 4.773 | 1.432 | 76 | 0 | 0 | 0 |
| Current Assets | 16 | 356 | 2.843 | 5.596 | 7.060 | 9.546 | 12.240 | 15.744 | 19.471 | 26.231 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54 | 270 |
| Cash | 16 | 356 | 2.843 | 5.596 | 7.060 | 9.546 | 12.240 | 15.744 | 19.417 | 25.961 |
| Shareholders Funds | -2.232 | -1.663 | -1.461 | 3.479 | 5.614 | 6.822 | 7.012 | 8.799 | 8.712 | 13.008 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.112 | 23.885 | 8.594 | 1.556 | 6.219 | 4.156 | 5.303 | 6.945 | 10.759 | 13.223 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Birjovanu S.r.l.